Psychoactive Effects of Medical Drugs

  • L. Eugene Arnold
  • Igor Janke
  • Brent Waters
  • Antony Milch


This chapter addresses the psychoactive effects of general medical drugs used in the treatment of children and adolescents with physical illnesses rather than psychotropic drugs prescribed for psychiatric or behavioral indications. “Psychoactive effects” will refer to acute or subacute effects in the behavioral, emotional, or cognitive domain. Anticonvulsant (antiepileptic) drugs are covered in Chapter 12. To avoid wordy repetition, the term “children” will mean “children and adolescents” unless otherwise indicated.


Acad Child Adolesc Psychiatry Central Nervous System Effect Medical Drug Antiparkinsonian Drug Psychoactive Effect 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Elliger TJ, Trott GE, Nissen G: Prevalence of psychotropic medication in childhood and adolescence in the Federal Republic of Germany. Pharmacopsychiatry 232:38–44, 1990.CrossRefGoogle Scholar
  2. 2.
    Australian Bureau of Statistics: Australian Health Survey Catalogue No. 4311.0, 1983.Google Scholar
  3. 3.
    Rylance GW, Woods CG, Cullen RE, et al: Use of drugs by children. Br Med J 297:445–448, 1988.CrossRefGoogle Scholar
  4. 4.
    Csik V, Molnar J: Possible adverse interaction between clozapine and ampicillin in an adolescent with schizophrenia. J Child Adolesc Psychopharmacol 4:123–128, 1994.CrossRefGoogle Scholar
  5. 5.
    Popper C: Developmental neurotoxicity, in Popper C (ed): Psychiatric Pharmacosciences of Children and Adolescents. Washington DC, American Psychiatric Press, 1989.Google Scholar
  6. 6.
    Rosenberg DA: Web of deceit: A literature review of Munchausen syndrome by proxy. Child Abuse Neglect 11:547–563, 1987.PubMedCrossRefGoogle Scholar
  7. 7.
    Whitlock FA: Adverse psychiatric reactions to modern medication. Aust N Z J Psychiatry 15:87–103, 1981.PubMedCrossRefGoogle Scholar
  8. 8.
    Harper CM, Newton PA, Walsh JR: Drug induced illness in the elderly. Postgrad Med 86:245–256, 1989.PubMedGoogle Scholar
  9. 9.
    Hollister LE: Drug-induced psychiatric disorders and their management. Med Toxicol 1:428–448, 1986.PubMedGoogle Scholar
  10. 10.
    Stoudemire A, Fogel BS: Principles of Medical Psychiatry. New York: Harcourt Brace & Jovanovich Publishers, 1989.Google Scholar
  11. 11.
    Dukes MNG: Meyler’s Side Effects of Drugs: An Encyclopaedia of Adverse Reactions and Interactions, ed 11. Amsterdam, Elsevier, 1988.Google Scholar
  12. 12.
    Dukes MNG, Beeley L: Side Effects of Drugs Annual 13: A Worldwide Yearly Survey of New Data and Trends. Amsterdam, Elsevier, 1989.Google Scholar
  13. 13.
    Boston Collaborative Drug Surveillance Program: Side effects of non-psychiatric drugs. Semin Psychiatry 3:406–420, 1971.Google Scholar
  14. 14.
    Evans LES: Psychological effects caused by drugs in overdose. Drugs 19:220–242, 1980.PubMedCrossRefGoogle Scholar
  15. 15.
    McClelland HA: Psychiatric disorders, in Davis DM (ed). Textbook of Adverse Drug Reactions. London: Oxford University Press, 1977, pp. 335–353.Google Scholar
  16. 16.
    American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, DC, American Psychiatric Association Press, 1994.Google Scholar
  17. 17.
    Rachelefsky GS, Wo J, Adelson J, et al: Behavior abnormalities and poor school performance due to oral theophylline use. Pediatrics 78:1133–1138, 1986.PubMedGoogle Scholar
  18. 18.
    Weinberger M, Lindgren S, Linder B, et al: Effects of theophylline on learning and behavior: Reason for concern or concern without reason? J Pediatr 111:471–474, 1987.PubMedCrossRefGoogle Scholar
  19. 19.
    Lindgren S, Lokshin B, Stromquist A, Weinberger M, et al: Does asthma or treatment with theophylline limit children’s academic performance? N Engl J Med 327:926–930, 1992.PubMedCrossRefGoogle Scholar
  20. 20.
    Tiplady B, Fagan D, Lamont M, Brockway M, Scott DB: A comparison of the CNS effects of enprofylline and theophylline in healthy subjects assessed by performance testing and subjective measures. Br J Clin Pharmacol 30:55–61, 1990.PubMedCrossRefGoogle Scholar
  21. 21.
    Suess WM, Chai H: Neuropsychological correlates of asthma: Brain damage or drug effects? J Consult Clin Psychol 49:135–136, 1981.PubMedCrossRefGoogle Scholar
  22. 22.
    Butz AM, Malveaux FJ, Eggleston P, Thompson L, et al: Social factors associated with behavioral problems in children with asthma. Clin Pediatr 34:581–590, 1995.CrossRefGoogle Scholar
  23. 23.
    Creer TL, Gustafson KE: Psychological problems associated with drug therapy in childhood asthma. J Pediatr 115:850–855, 1989.PubMedCrossRefGoogle Scholar
  24. 24.
    Furukawa CT, DuHamel TR, Weimer L, et al: Cognitive and behavioral findings in children taking theophylline. J Allergy Clin Immunol. 81:83–88, 1988.PubMedCrossRefGoogle Scholar
  25. 25.
    Schlieper A, Alcock D, Beaudry P, et al: Effect of therapeutic plasma concentrations of theophylline on behavior, cognitive processing and affect in children with asthma. J Pediatr 118:449–455, 1991.PubMedCrossRefGoogle Scholar
  26. 26.
    Creer TL, McLoughlin JA: The effects of theophylline on cognitive and behavioral performance. J Allergy Clin Immunol 83:1027–1029, 1989.PubMedCrossRefGoogle Scholar
  27. 27.
    Bartel P, Delport R, Lotz B, Ubbink J, et al: Effects of single and repeated doses of theophylline on aspects of performance, electrophysiology, and subjective assessments in healthy human subjects. Psychopharmacol-ogy 106:90–96, 1992.CrossRefGoogle Scholar
  28. 28.
    Schraa JC, Dirks JF: The influence of corticosteroids and theophylline on cerebral function. Chest 82:181 – 185, 1982.PubMedCrossRefGoogle Scholar
  29. 29.
    Bender BG, Lerner JA, Kollasch E: Mood and memory changes in asthmatic children receiving corticosteroids. J Am Acad Child Adolesc Psychiatry 27:720–725, 1988.PubMedCrossRefGoogle Scholar
  30. 30.
    Suess W, Stump N, Chi H, et al: Mnemonic effects of asthma medication in children. J Asthma 23:291–296, 1986.PubMedCrossRefGoogle Scholar
  31. 31.
    Lewis LD, Cochrane GM: Psychosis in a child inhaling budesonide. Lancet 2:634, 1983.PubMedCrossRefGoogle Scholar
  32. 32.
    Meyboom RHB, DeGraaf-Breederveld N: Budesonide and psychic side effects. Ann Intern Med 109:683, 1988.PubMedCrossRefGoogle Scholar
  33. 33.
    Hollman GA, Allen DB: Overt glucocorticoid excess due to inhaled corticosteroid therapy. Pediatrics 81: 452–455, 1988.PubMedGoogle Scholar
  34. 34.
    Rohatiner AZS, Proir PF, Burton AC, et al: Central nervous system toxicity of interferon. Br J Cancer 47:419–442, 1983.PubMedCrossRefGoogle Scholar
  35. 35.
    Spiegel RF: The alpha-interferons: Clinical overview. Semin Oncol 14(suppl 2):1–12, 1987.PubMedGoogle Scholar
  36. 36.
    Cousens P, Waters BGH, Said J, et al: Cognitive effects of cranial-irradiation in leukemia: A survey and metaanalysis. Child Psychol Psychiatry 29:839–852, 1988.CrossRefGoogle Scholar
  37. 37.
    Waters BGH, Said J, Cousens P, et al: Behavioral side effects of CNS prophylaxis. J Am Acad Child Adolesc Psychiatry 28:299–300, 1989.PubMedCrossRefGoogle Scholar
  38. 38.
    Prugh DG, Wagonfeld S, Metcalf D, et al: A clinical study of delirium in children and adolescents. Psychosom Med 42(suppl):177–195, 1980.PubMedGoogle Scholar
  39. 39.
    Lipowski ZJ: Delirium (acute confusional states). JAMA 258:1789–1792, 1987.PubMedCrossRefGoogle Scholar
  40. 40.
    Trzepacz PT, Teague GB, Lipowski ZJ: Delirium and other organic mental disorders in a general hospital. Gen Hosp Psychiatry 7:101–106, 1985.PubMedCrossRefGoogle Scholar
  41. 41.
    Goodman JD, Sours JA: The Child Mental Status Examination. New York: Basic Books, 1967.Google Scholar
  42. 42.
    McEwen J, Meyboom RH, Thijs I: Hallucinations in children caused by oxolamine citrate. Med J Aust 150:449–450,452, 1989.PubMedGoogle Scholar
  43. 43.
    Kortabarria RP, Duran JA, Chacon JR, et al: Toxic psychosis following cycloplegic eyedrops. Drug Intell Clin Pharm 24:708–709, 1990.Google Scholar
  44. 44.
    Eisendrath S J, Ostroff JW: Ranitidine-associated delirium. Psychosomatik 31:98–100, 1990.CrossRefGoogle Scholar
  45. 45.
    Sax MJ: Clinically important adverse effects and drug interactions with H2-receptor antagonists: An update. Pharmacotherapy 7:110S-115S, 1987.Google Scholar
  46. 46.
    Ahamad S, Sheikh AI, Meerian MK: Disopyramide-induced acute psychosis. Chest 16:712–714, 1979.CrossRefGoogle Scholar
  47. 47.
    Bushe VJ: Organic psychosis caused by diltiazem. J R Soc Med 81:296, 1988.Google Scholar
  48. 48.
    Johnson AJ, Day RO, Shaldon WA: A functional psychosis precipitated by quinidine. Med J Aust 153:47–49, 1990.PubMedGoogle Scholar
  49. 49.
    Arbor N: Delirium induced by atenolol. Br Med J 297:1048, 1988.CrossRefGoogle Scholar
  50. 50.
    Banergee AK, Falkai PG, Savidge M: Visual hallucinations in the elderly associated with the use of levodopa. Postgrad Med J 65:358–361, 1989.CrossRefGoogle Scholar
  51. 51.
    Snoey ER, Bessen HA: Acute psychosis after amantadine overdose. Ann Emerg Med 19:668–670, 1990.PubMedCrossRefGoogle Scholar
  52. 52.
    Silber TJ, D’Angelo L: Psychosis and seizures following the injection of penicillin G procaine: Hoigne’s syndrome. Am J Dis Child 139:335–337, 1985.PubMedGoogle Scholar
  53. 53.
    Ilechukwu STC: Acute psychotic reactions and stress response syndromes following intramuscular aqueous procaine penicillin. Br J Psychiatry 156:554–559, 1990.PubMedCrossRefGoogle Scholar
  54. 54.
    Arndt KA: Adverse reactions to acyclovir: Topical, oral, and intravenous. J Am Acad Dermatol 18:188–190, 1988.PubMedCrossRefGoogle Scholar
  55. 55.
    Meyers EF, Charles P: Prolonged adverse reactions to ketamine in children. Anesthesiology 49:39–40, 1978.PubMedCrossRefGoogle Scholar
  56. 56.
    Holm-Knudsen R, Nygard E, Laub M: Rectal induction of anesthesia in children: A comparison between ketamine-midazolam and halothane for induction and maintenance of anesthesia. Acta Anaesthesiol Scand 33:518–521, 1989.PubMedCrossRefGoogle Scholar
  57. 57.
    Hurwitz RL, Mahoney DH Jr, Armstrong DL, et al: Reversible encephalopathy and seizures as a result of conventional vincristine administration. Med Pediatr Oncol 16:216–219, 1988.PubMedCrossRefGoogle Scholar
  58. 58.
    Young D, Posner J: Nervous system toxicity of the chemotherapeutic agents, in Viken PJ, Bruyn GW (eds). Handbook of Clinical Neurology, vol 39, pt II. Amsterdam, Elsevier Biomedical Press, 1980.Google Scholar
  59. 59.
    Cuthbert MF: Adverse reactions to nonsteroidal antirheumatic drugs. Curr Med Res Opin 2:600–610, 1974.PubMedCrossRefGoogle Scholar
  60. 60.
    Greer HD, Ward HP, Corbin KB: Chronic salicylate intoxication in adults. JAMA 193:555–558, 1965.PubMedCrossRefGoogle Scholar
  61. 61.
    Elliott RL, Wilde JH, Snow WT: Prolonged delirium after metrizamide myelography. JAMA 252:2057–2058, 1984.PubMedCrossRefGoogle Scholar
  62. 62.
    Haslam RHA, Cochrane DD, Amundson GM, et al: Neurotoxic complications of contrast computed tomography in children. J Pediatr III 6:837–840, 1987.CrossRefGoogle Scholar
  63. 63.
    Montastruc JL, Rascol D, Rascol A: Comparison of bromocriptine and levodopa as first line treatment for Parkinson’s disease: Results of a 3 year prospective randomized study. Rev Neurol 146:144–147, 1990.PubMedGoogle Scholar
  64. 64.
    Havener WH: Ocular Pharmacology, ed 4. St. Louis, CV Mosby Co, 1978.Google Scholar
  65. 65.
    Khanna PB, Davies R: Hallucinations associated with administration of salbutamol via a nebulizer. Br Med J 292:1430, 1986.CrossRefGoogle Scholar
  66. 66.
    Krauthammer C, Klerman GL: Secondary mania: Manic syndromes associated with antecedent physical illness or drugs. Arch Gen Psychiatry 35:1333–1339, 1978.PubMedCrossRefGoogle Scholar
  67. 67.
    Ritchie KS, Preskorn SH: Mania induced by metoclopramide: Case report. J Clin Psychiatry 45:180–181, 1984.PubMedGoogle Scholar
  68. 68.
    Vlissides DN, Gill D, Castelow MJ: Bromocriptine-induced mania? Br Med J 1:510, 1978.PubMedCrossRefGoogle Scholar
  69. 69.
    Larson EW, Richelson E: Organic causes of mania. Mayo Clin Proc 63:906–912, 1988.PubMedCrossRefGoogle Scholar
  70. 70.
    Boston Collaborative Drug Surveillance Program: Acute adverse reactions to prednisone in relation to dosage. Clin Pharmacol 13:694–698, 1972.Google Scholar
  71. 71.
    Minden SL, Orau J, Schildkraut JJ: Hypomanic reactions to ACTH and prednisone treatment for multiple sclerosis. Neurology 38:1631–1634, 1988.PubMedCrossRefGoogle Scholar
  72. 72.
    Maxwell S, Scheftner WA, Kessler HA, et al: Manic syndrome associated with zidovudine treatment. JAMA 259:3406, 1989.CrossRefGoogle Scholar
  73. 73.
    Wright JM, Sachdev PS, Perkins RJ, et al: Zidovudine-related mania. Med J Aust 150:339–341, 1989.PubMedGoogle Scholar
  74. 74.
    Waters BGH, Simeon J: Behavioral toxicity to medications in a six year old boy: A genetic marker? J Am Acad Child Psychiatry 22:492–494, 1983.PubMedCrossRefGoogle Scholar
  75. 75.
    Shader RI: Psychiatric Complications of Medical Drugs. New York: Raven Press, 1972.Google Scholar
  76. 76.
    Editorial: Br Med J 180:119–120, 1966.Google Scholar
  77. 77.
    Demuth GW, Ackerman SH: Alpha-methyldopa and depression: A clinical study and a review of the literature. Am J Psychiatry 140:534–538, 1983.PubMedGoogle Scholar
  78. 78.
    Campbell M, Spencer EK: Psychopharmacology in child and adolescent psychiatry: A review of the past five years. J Am Acad Child Adolesc Psychiatry 27:269–279, 1988.PubMedCrossRefGoogle Scholar
  79. 79.
    Patten SB: Propranolol and depression: Evidence from the antihypertensive trials. Can J Psychiatry 35:257–259, 1990.PubMedGoogle Scholar
  80. 80.
    Brismar K, Hylander B, Eliasson K, et al: Melatonin secretion related to side effects of beta blockers from the central nervous system. Acta Med Scand 223:525–530, 1988.PubMedCrossRefGoogle Scholar
  81. 81.
    Bright RA, Everitt DE: Beta-blockers and depression: Evidence against an association. JAMA 267:1783–1787, 1992.PubMedCrossRefGoogle Scholar
  82. 82.
    Hullett FJ, Potkin SG, Levy AB, et al: Depression associated with nifedipine-induced calcium channel blockade. Am J Psychiatry 145:1277–1279, 1988.PubMedGoogle Scholar
  83. 83.
    Caufman M, Kahner K, Paselow ED, et al: Steroid psychoses: Case report and brief overview. J Clin Psychiatry 43:75–76, 1982.Google Scholar
  84. 84.
    Burke P, Kocoshis SA, Chandra R, et al: Determinants of depression in recent onset paediatric inflammatory bowel disease. J Am Acad Child Adolesc Psychiatry 29:608–610, 1990.PubMedCrossRefGoogle Scholar
  85. 85.
    Ruthgers AWF, Links TP, LeCoultre R, et al: Behavioral disturbances after effective ACTH treatment of the dancing eye syndrome. Dev Med Child Neurol 30:408, 1988.CrossRefGoogle Scholar
  86. 86.
    Venkatarangam SH, Kutcher SP, Notkin RM: Secondary mania with steroid withdrawal. Can J Psychiatry 33:631–632, 1988.PubMedGoogle Scholar
  87. 87.
    Stiefel FC, Breitbart WS, Holland JC: Corticosteroids in cancer: Neuropsychiatrie complications. Cancer Invest 7:479–491, 1989.PubMedCrossRefGoogle Scholar
  88. 88.
    Gawkrodger D: Manic depression induced by dapsone in patients with dermatitis herpetiformis. Br Med J 30:860, 1989.CrossRefGoogle Scholar
  89. 89.
    Pope HG Jr, Katz DL: Affective and psychotic symptoms associated with anabolic steroid use. Am J Psychiatry 145:487–490, 1988.PubMedGoogle Scholar
  90. 90.
    Slap GB: Oral contraceptives and depression. Impact, prevalence and cause. J Adolesc Health Care 2:53–64, 1981.PubMedCrossRefGoogle Scholar
  91. 91.
    Fleming O, Seager CP: Incidence of depressive symptoms in users of the oral contraceptive. Br J Psychiatry 132:431–440, 1978.PubMedCrossRefGoogle Scholar
  92. 92.
    Glick ID, Bennett SE: Psychiatric complications of progesterone and oral contraceptives. J Clin Psychophar-macol 6:350–367, 1981.CrossRefGoogle Scholar
  93. 93.
    Shear MK: Pathophysiology of panic: A review of pharmacologic provocative tests and naturalistic monitoring data. J Clin Psychiatry 47(suppl):18, 1986.PubMedGoogle Scholar
  94. 94.
    Ministry of Health and Welfare, Tokyo: Angioneurotic oedema induced by enalapril maleate or Captopril. Information on Adverse Reactions to Drugs, No. 84, 1987.Google Scholar
  95. 95.
    West Midlands Centre for Adverse Drug Reactions Reporting: ACE inhibitors and CNS adverse effects. Newsletter, June 1988.Google Scholar
  96. 96.
    Burns EM, Arnold LE: Biological aspects of stress: Effects on the developing brain, in: Arnold LE (ed): Childhood Stress. New York: John Wiley & Sons, 173–138, 1990.Google Scholar

Copyright information

© Springer Science+Business Media New York 1999

Authors and Affiliations

  • L. Eugene Arnold
    • 1
  • Igor Janke
    • 2
  • Brent Waters
    • 3
  • Antony Milch
    • 4
  1. 1.Ohio State UniversityColumbusUSA
  2. 2.Department of PsychiatryOhio State UniversityColumbusUSA
  3. 3.Edgecliff CentreEdgecliffAustralia
  4. 4.Queenscliff Health CentreManly Hospital and Community Health ServicesNorth ManlyAustralia

Personalised recommendations